✦ LIBER ✦
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes
✍ Scribed by J. Rosenstock; M. Davies; P. D. Home; J. Larsen; C. Koenen; G. Schernthaner
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 179 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0012-186X
No coin nor oath required. For personal study only.